中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2015年
7期
530-531,543
,共3页
长链非编码RNA%人宫颈癌%顺铂%耐药
長鏈非編碼RNA%人宮頸癌%順鉑%耐藥
장련비편마RNA%인궁경암%순박%내약
long non-coding RNA%human cervical cancer%cisplatin%drug resistance
目的:研究肺腺癌转移相关转录子1( MALAT1)对人宫颈癌癌Hela细胞顺铂化疗敏感性的影响。方法用RNA干扰( RNAi)技术下调MALAT1在人宫颈癌Hela细胞中的表达,对Hela细胞用顺铂1 mg· L-1进行处理。用细胞计数法检测不同时间点Hela细胞增殖能力的变化,用流式细胞检测Hela细胞周期变化。结果 RNAi下调MALAT1表达后,Hela细胞对顺铂化疗敏感性显著增高,而细胞增殖能力明显下降(均 P <0.05)。 G0/G1期细胞比率明显增高( P<0.05) ,Hela细胞迁移能力显著降低( P<0.05)。结论抑制长链非编码RNA MALAT1可增强人宫颈癌Hela细胞对顺铂化疗的敏感性。
目的:研究肺腺癌轉移相關轉錄子1( MALAT1)對人宮頸癌癌Hela細胞順鉑化療敏感性的影響。方法用RNA榦擾( RNAi)技術下調MALAT1在人宮頸癌Hela細胞中的錶達,對Hela細胞用順鉑1 mg· L-1進行處理。用細胞計數法檢測不同時間點Hela細胞增殖能力的變化,用流式細胞檢測Hela細胞週期變化。結果 RNAi下調MALAT1錶達後,Hela細胞對順鉑化療敏感性顯著增高,而細胞增殖能力明顯下降(均 P <0.05)。 G0/G1期細胞比率明顯增高( P<0.05) ,Hela細胞遷移能力顯著降低( P<0.05)。結論抑製長鏈非編碼RNA MALAT1可增彊人宮頸癌Hela細胞對順鉑化療的敏感性。
목적:연구폐선암전이상관전록자1( MALAT1)대인궁경암암Hela세포순박화료민감성적영향。방법용RNA간우( RNAi)기술하조MALAT1재인궁경암Hela세포중적표체,대Hela세포용순박1 mg· L-1진행처리。용세포계수법검측불동시간점Hela세포증식능력적변화,용류식세포검측Hela세포주기변화。결과 RNAi하조MALAT1표체후,Hela세포대순박화료민감성현저증고,이세포증식능력명현하강(균 P <0.05)。 G0/G1기세포비솔명현증고( P<0.05) ,Hela세포천이능력현저강저( P<0.05)。결론억제장련비편마RNA MALAT1가증강인궁경암Hela세포대순박화료적민감성。
Objective To evaluate the biological function of metastasis-associated lung adenocarcinoma transcript 1 ( MALAT1 ) associated with cisplatin resistance in Hela cell.Methods MALAT1 expression was know down by RNA interfere technology in human cervical carcinoma cell Hela.And the Hela cell was treated by 10 mg · L-1 cisplatin.The cell proliferation was tested by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2 -H -tetrazolium bromide ( MTT ) array and cell cycle was tested by Flow cytometry assay.Results The cell proliferation was significant inhibit when decrease the expression in Hela cell ( P<0.05 ) . Which demonstrated that the inhibit MALAT 1 Hela cell was sensitive to cisplatin.And the G0/G1 cell cycle proportion was significant increased than the control group ( P <0.05 ).The migration ability in the si-MALAT1 Hela cell was significant decreased ( P<0.05 ).Conclu-sion Know down MALAT1expression can significant increase the cispla-tin sensitivity in human cervical cancer Hela cell.